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Vertebrate circadian rhythms are organized by
the hypothalamic suprachiasmatic nucleus (SCN).
Despite its physiological importance, SCN develop-
ment is poorly understood. Here, we show that Lim
homeodomain transcription factor 1 (Lhx1) is essen-
tial for terminal differentiation and function of the
SCN. Deletion of Lhx1 in the developing SCN results
in loss of SCN-enriched neuropeptides involved
in synchronization and coupling to downstream
oscillators, among other aspects of circadian func-
tion. Intact, albeit damped, clock gene expression
rhythms persist in Lhx1-deficient SCN; however,
circadian activity rhythms are highly disorganized
and susceptible to surprising changes in period,
phase, and consolidation following neuropeptide
infusion. Our results identify a factor required for
SCN terminal differentiation. In addition, our in vivo
study of combinatorial SCN neuropeptide disruption
uncovered synergies among SCN-enriched neuro-
peptides in regulating normal circadian function.
These animals provide a platform for studying the
central oscillator’s role in physiology and cognition.INTRODUCTION
Circadian rhythms restrict physiological functions including
sleep/wake, feeding, thermoregulation, and hormone release
to appropriate temporal niches. This behavior is proximally
controlled by cellular circadian clocks. During the cellular clock’s
rising phase, Bmal1/Clock heterodimers drive transcription of
clock genes including Per1/2/3 and Cry1/2, whose productsinhibit their own transcription during the falling phase (reviewed
in Albrecht, 2012).
Despite the ubiquity of cellular clocks in the body, the supra-
chiasmatic nucleus (SCN) of the anteroventral hypothalamus
acts as a master regulator of light-entrained circadian rhythms,
a role facilitated by a number of remarkable properties unique
to its cells. In dispersed culture conditions, SCN neurons spon-
taneously synchronize their circadian clocks, unlike any other
cell type (Ko et al., 2010). SCN slice cultures also sustain robust
circadian oscillations for weeks, unlike most other neural regions
(Abe et al., 2002; Tosini and Menaker, 1996). Finally, while the
SCN is uniquely susceptible to direct phase-shifting by light
signals from intrinsically photosensitive retinal ganglion cells
(ipRGCs), it is exceptionally resistant to resetting by nonlight
cues that phase-shift peripheral clocks (Buhr et al., 2010; Hattar
et al., 2002). These properties rely on a robust SCN network that
strengthens and coordinates the unstable oscillations of its indi-
vidual cellular clocks, thereby organizing output signals that
entrain the rest of the body (Albrecht, 2012; Ciarleglio et al.,
2009; Romijn et al., 1997; Vasalou et al., 2009;Webb et al., 2009).
Neuropeptides prominently and selectively expressed in the
SCN are heavily implicated in the regulation of the SCN network.
Vasoactive intestinal peptide (Vip) is a key organizer of SCN
cellular rhythms and activity; genetic disruption of Vip or its re-
ceptor, Vipr2, reduces the proportion and synchrony of circadian
SCN cells (Aton et al., 2005; Maywood et al., 2006, 2011) and
disrupts SCN electrical activity rhythms (Brown et al., 2007) as
well as circadian- and light-entrained locomotion (Aton et al.,
2005; Colwell et al., 2003; Harmar et al., 2002). Another critical
component is prokineticin-2 (Prok2), a major SCN output signal
(Cheng et al., 2002; Prosser et al., 2007). Gastrin-releasing
peptide (Grp) and arginine vasopressin (Avp) also contribute to
SCN gene expression rhythms, electrical rhythms, and output,
while enkephalin (Enk) may gate SCN responsiveness to light
(Albers et al., 1995; Brown et al., 2005; Harrington et al., 1993;
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Vansteensel et al., 2005; Wideman et al., 2000). In mice, exoge-
nous neuromedin S (Nms) alters circadian behavior but has
unknown endogenous roles (Mori et al., 2005). Numerous other
canonical neuropeptides are also present in SCN, and unbiased
studies have identified dozens more whose characterization has
only just begun (Abrahamson and Moore, 2001; Atkins et al.,
2010; Lee et al., 2010).
SCN cellular heterogeneity implies complex developmental
pathways guiding its differentiation and the emergence of its
unique circadian properties. To date, three transcription factors
involved in SCN development have been identified: Six3, Six6,
and Lhx2. Deletion of any one of these factors prevents SCN
specification from hypothalamic neuroepithelium (Clark et al.,
2013; Roy et al., 2013; VanDunk et al., 2011). These factors are
broadly expressed in developing ventral forebrain (Jean et al.,
1999; Oliver et al., 1995; Xu et al., 1993), and all SCN gene
expression and structural markers are undetectable after their
genetic disruption (Clark et al., 2013; Roy et al., 2013; VanDunk
et al., 2011), providing little insight into later stages of SCN
differentiation. Therefore, nothing is yet known about the tran-
scriptional regulatory network controlling expression of SCN-
enriched neuropeptides such as Vip and Avp.
Unlike Six3, Six6, and Lhx2, hypothalamic expression of other
transcription factors is restricted to the SCN during develop-
ment, the earliest of which is LIM homeodomain transcription
factor 1 (Lhx1) (Shimogori et al., 2010; VanDunk et al., 2011).
Lhx1 guides differentiation of other neural subtypes outside the
hypothalamus, including cerebellar Purkinje cells (Zhao et al.,
2007) and hindbrain reticulospinal neurons (Cepeda-Nieto
et al., 2005). Intriguingly, it also dictates neuropeptide fate of
specific cell subpopulations during spinal cord development
(Bro¨hl et al., 2008).
We find that Lhx1 is necessary for SCN terminal differentiation,
including expression of neuropeptides profoundly important for
circadian function. Despite only modest changes in variability
and synchronization of cellular rhythms, circadian locomotor
activity rhythms were severely disorganized and vulnerable
to neuropeptidergic disturbance of consolidation, phase, and
period in mice with Lhx1 selectively deleted in anterior hypothal-
amus. Our study identifies a transcription factor involved in SCN
terminal differentiation. The Six3-Cre;Lhx1lox/lox mouse also pro-
vides a behavioral model with several emergent properties not
seen in animals with deficits in a single-neuropeptide pathway,
providing insight into the synergistic nature of the SCN neuro-
peptide network.
RESULTS
Selective Deletion of Lhx1 in Ventral Anterior
Hypothalamus
Because conventional Lhx1 null mice lack anterior neural struc-
tures (Shawlot and Behringer, 1995), we used an intersectional
approach to more specifically delete Lhx1 in the developing
anterior hypothalamus by crossing a conditional allele to
transgenic Six3-Cre mice (Furuta et al., 2000; Kwan and Beh-
ringer, 2002). As previously reported, Six3-Cre activity was
more spatially restricted than native Six3 expression (Furuta
et al., 2000). Six3-Cre;ROSA26::YFP mice had robust Cre610 Cell Reports 7, 609–622, May 8, 2014 ª2014 The Authorsactivity in the ventral telencephalon and ventral anterior hypo-
thalamus, including the SCN and subparaventricular zone
(SPZ). However, Six3-Cre;ROSA26::YFP mice lacked Cre
activity in more posterior regions that express Lhx1 during em-
bryonic development, such as the intergeniculate leaflet (IGL),
dorsomedial hypothalamus, and mamillary nucleus (Figures
S1A and S1B). Lhx1 in situ hybridization (ISH) revealed that
Six3-Cre;Lhx1lox/lox mice reliably and specifically lost Lhx1
expression in the ventral anterior hypothalamus, including
the SCN and SPZ (Figures S1C–S1E and S1I). Although tran-
sient Lhx1 expression in anterior hypothalamic nucleus and
anterior lateral hypothalamus were also lost at postnatal
day 0 (P0) (Figure S1I), neither region has any established circa-
dian function. Lhx1 was normally expressed in more posterior
regions important for circadian rhythmicity and motor output
(e.g., IGL, cerebellum) as well as the medial preoptic area (Fig-
ures S1F–S1H).
Lhx1 Deletion Disrupts SCN-Enriched Neuropeptide
Expression
We next examined neuropeptide expression in Six3-Cre;
Lhx1lox/lox and Lhx1lox/lox control SCN by ISH. Neuropeptides
implicated in circadian function were downregulated (Figures
1A–1G; Table S1), including Vip, Prok2, Grp, Avp, Enk, and
Nms (p < 0.05 for all except Grp, and p < 0.005 for Grp). Down-
regulation was not observed in other brain regions (Figures 1A–
1F). SCN neuropeptide loss was not caused by the Cre driver
alone, because Six3-Cre;Lhx1+/+ mice had normal expression
of Vip, Grp, Avp, and Lhx1 (Figures S1J–S1M).
Importantly, other SCN markers were largely unaffected by
Lhx1 deletion (Figures 2 and S2). GABAergic markers such as
Gad67, Calb1, and Calb2 were retained (Figures 2A–2C), as
were SCNmarkers first expressed prior to induction of circadian
neuropeptides during development, such as Vipr2, Id4, Arx,
Dlx2, Nr1d1, and Rorb (Figures 2D and S2A–S2E). Neuropep-
tides broadly expressed in the anterior hypothalamus were
also mostly preserved in Six3-Cre;Lhx1lox/lox SCN, including
Sst, Agt,Nts,Cck,Gal, and Scg2 (Figures S2F–S2K). Expression
of Pcsk1n, required for proteolytic processing of many neuro-
peptide precursors, is also preserved (Figure S2L). Importantly,
most markers normally restricted to specific SCN subdomains
showed similar compartmentalization in mutants. For instance,
Calb2 localized to ventral core, Rorb localized to shell, and
Vipr2 expression remained weak in the center of the SCN (Fig-
ures 2C and 2D and S2E).
Lhx1 Deletion Causes Neuron Loss and Cell Death in
Developing SCN
Pan-SCN ISH markers showed that Six3-Cre;Lhx1lox/lox SCN
was smaller than controls; therefore, we performed immunohis-
tochemistry (IHC) for the pan-neuronal marker HuC/D and found
that SCN neuron number was significantly reduced in Six3-
Cre;Lhx1lox/lox adults (p < 0.05). To determine when neuron
loss occurred in Six3-Cre;Lhx1lox/lox SCN, we conducted
HuC/D IHC at multiple developmental time points (Figures 2E
and S3M). There were main effects of both genotype and
age (p < 0.0005) and significant interaction (p < 0.05). SCN
neuron number was normal at P0 in Six3-Cre;Lhx1lox/lox mice
Figure 1. Lhx1 Effects on SCN Neuropep-
tides
(A–F0) ISH of SCN from adult Lhx1lox/lox control
(A–F) and Six3-Cre;Lhx1lox/lox mutant (A0–F0) mice
for Vip (A, A0 ), Prok2 (B, B0),Grp (C, C0), Avp (D, D0),
Enk (E, E0), and Nms (F, F0). Insets show the
neocortex (A and C), preoptic area (B, E, and F),
and paraventricular nucleus (D). Scale bar repre-
sents 100 mm.
(G) Mutants had fewer neuropeptide ISH-labeled
SCN cells than controls (n = 3, paired two-tailed
t tests, *p < 0.05, **p < 0.01; graph depicts mean ±
SEM).
(H) MOPAT bioinformatics analysis showed more
putative Lhx1-binding sites in enhancers of an
SCN-enriched gene pool compared to a randomly
selected pool (pool shown in Table S2; method
described in Hu et al., 2008; binomial distribution,
*p < 0.05).(p = 0.95), but significantly fewer SCN neurons were present by
P4 in Six3-Cre;Lhx1lox/lox SCN compared to controls (p < 0.0005)
(Figures 2E andS2M). No further loss of neuronswas observed in
Six3-Cre;Lhx1lox/lox SCN after P4, although neuron number
continued to decrease gradually in control SCN into adulthood
(p < 0.05); this dropped the previously noted genotype difference
in adult neuron number slightly below significance (p = 0.07) in
the context of the time course.
To examine whether decreased neuron number between P0
and P4 in Lhx1-deficient SCN resulted from increased develop-
mental apoptosis, we conducted TUNEL experiments in P0–P3
SCN. A main effect of genotype (p < 0.005) indicated an aggre-Cell Reports 7, 609gate increase in TUNEL-positive cells
across the time course in Six3-Cre;
Lhx1lox/lox SCN, although no individual
time points were significant (Figures 2F
and S2N). There was also a main effect
of age (p < 0.0005) but no interaction
(p = 0.30).
Reduction in Neuropeptide Gene
Expression Is Not Caused by
Selective Neuron Loss in Lhx1-
Deficient SCN
To examine whether neuron loss could
explain SCN neuropeptide depletion in
our mutants, we measured neuropeptide
expression by ISH at P0, when Six3-
Cre;Lhx1lox/lox SCN neuron number is
normal (Figures 2G and S2O–S2R). Vip,
Avp, and Grp were already profoundly
downregulated in mutant SCN, indi-
cating that loss of neuropeptide gene
expression precedes neuron loss (all
p < 0.05; Figure 2G). Prok2 expression
was very low and variable in controls,
making comparison with mutants unin-
terpretable (Figure 2G). We did notdetect Enk or Nms in control or mutant SCN by ISH at P0
(data not shown).
We then conducted in silico MOPAT analysis to determine
whetherLhx1mightdirectly regulateexpressionofSCN-enriched
neuropeptides. A greater proportion of evolutionarily conserved
predicted Lhx1 consensus binding sites were present within
proximal regulatory regions of SCN-enriched genes relative to
randomly selected genes (Figure 1H). SCN-enriched genes
bearing putative Lhx1 binding sites included the three neuropep-
tide genes with the greatest percent reduction in Six3-Cre;
Lhx1lox/lox mice (Vip, Prok2, and Nms) as well as Enk, which was
not included in our initial analysis (Figures 1G and 1H; Table S2).–622, May 8, 2014 ª2014 The Authors 611
Figure 2. SCN Regional Identity Is Pre-
served in Six3-Cre;Lhx1lox/lox Mice, but Cell
Death Is Elevated in Neonatal SCN
(A–D) ISH of SCN from Lhx1lox/lox control (A–D) and
Six3-Cre;Lhx1lox/lox adult mutant (A0–D0) mice for
Gad67 (A, A0), Calb1 (B, B0), Calb2 (C, C0), and
Vipr2 (D, D0).
(E) Mutants had fewer SCN neurons than con-
trols at P4 and P7 (n = 3, 3, 3, 3, ANOVA
and Tukey post hoc tests, *p < 0.05, ***p <
0.0005; graph depicts mean ± SEM). Mutant
SCN neuron number in adults was significantly
lower than controls when initially analyzed on
its own by t test (p < 0.05) but fell just short of
significance in the context of the time course
(p = 0.07).
(F) Mutants had increased SCN cell death in
the aggregate period between P0 and P3 com-
pared to controls, but the age(s) within this
range with elevated cell death could not be
pinned down (n = 3, 4, 4, 3, ANOVA with post
hoc Tukey tests, **p < 0.005; graph depicts
mean ± SEM).
(G) Mutants had fewer Vip, Grp, and Avp, but not
Prok2, expressing SCN cells than controls at P0
(n = 3, 3, 3, 3, paired two-tailed t tests, *p < 0.05;
graph depicts mean ± SEM).SCN Clock Gene Expression Rhythms Are Preserved
after Lhx1 Deletion
Despite profoundly decreased neuropeptide expression, biolu-
minescence recordings from Six3-Cre;Lhx1lox/lox;Per2luc/+ SCN
cultures revealed clock gene rhythms with similar circadian
period compared to controls from two independently tested
groups of mice. Mean bioluminescence was similar in the
first cohort but lower in the experimental group in the
second cohort (Mann-Whitney U test, p < 0.01). Lhx1-
deficient SCN had reduced peak-to-trough Per2 rhythm
amplitude and more rapid damping in both cohorts (p <
0.05, Student’s t test; Figure 3A). Higher-resolution charge-
coupled device (CCD) camera data revealed that this was
attributable to reduced circadian synchrony (Figure 3B) and
increased circadian period variability within each Six3-
Cre;Lhx1lox/lox SCN relative to controls (p < 0.001, Student’s
t test; Figure 3C).
We confirmed a similar pattern in vivo via a 24 hr ISH time
course of the core clock genes Per1 and Per2 and the clock-
controlled gene Avp. There were main effects of circadian time
for all three genes tested in Six3-Cre;Lhx1lox/lox SCN and con-
trols in constant darkness (DD) (Per1 p < 0.001; Per2 p <
0.0001; Avp p < 0.0001) (Figures 3D–3F and S3A–S3C). A main
effect of genotype and an interaction were observed for Per2
(p < 0.0001, p < 0.01) and Avp (both p < 0.0001), but not Per1
(p = 0.09, p = 0.27) (Figures 3D–3F and S3A–S3C). Vip mRNA612 Cell Reports 7, 609–622, May 8, 2014 ª2014 The Authorswas also examined but was virtually
absent at all circadian time points (data
not shown). Thus, both core clock
and clock-controlled gene expression is
still temporally regulated over circadiantime, albeit with reduced amplitude for some genes, in the
SCNs of intact Six3-Cre;Lhx1lox/lox mice.
Disrupted Circadian Activity Rhythms in Lhx1-
Deficient Mice
Because lower-amplitude oscillations more readily phase shift
to out-of-phase light exposure (Pulivarthy et al., 2007), we
reasoned that Six3-Cre;Lhx1lox/lox animals would more readily
entrain and reset to light cues than controls. Instead, activity of
Six3-Cre;Lhx1lox/lox mice entrained less robustly than controls
under a 12:12 light:dark cycle (LD) (Figure 4A), with a small
advanced phase angle of nocturnal wheel running into the light
phase and a reduced percentage of overall activity confined to
the dark phase (Figures 4B and 4C). Inmanyways, these LD phe-
notypes seem similar to those seen in Vip/mice, leading us to
initially hypothesize that Vip loss alone underpinned the behav-
ioral deficits of Six3-Cre;Lhx1lox/lox mutants.
However, this proved incomplete when we examined the ani-
mals in DD. Despite moderate damping and desynchrony phe-
notypes in Lhx1-deficient SCN similar to or milder than previous
descriptions of Vip/ and Vipr2/ SCN rhythms (Aton et al.,
2005; Brown et al., 2007; Maywood et al., 2011), free-running ac-
tivity rhythms of Lhx1-deficient mice were profoundly disorga-
nized (Figure 4D). A total of 50% of Six3-Cre;Lhx1lox/lox mice
lacked measurable rhythms within 3 days of entry into DD, while
the remainder showed two or even three distinct split rhythms,
Figure 3. Lhx1 Effects on SCN Clock Gene Rhythms
(A) Adult Lhx1lox/lox (left) and Six3-Cre;Lhx1lox/lox (right) mouse SCN explants showed near-24 hr cycling of Per2::Luc bioluminescence over 10 days of recording,
with moderately damped amplitude in the mutant explants. Traces show mean (black line) and SD (gray) of bioluminescence collected at 1 min intervals from 8
Lhx1lox/lox (left) and 9 Six3-Cre; Lhx1lox/lox (right) explants.
(B) Raster plots demonstrate variations in synchrony of circadian rhythms across regions of interest (ROIs) from one representative control (left) and one
Six3Cre;Lhx1lox/lox SCN explant (right). White bars cover the region where data were lost while recording (40–46 hr).
(C) Loss of Lhx1 caused greater variance of circadian period in Six3-Cre;Lhx1lox/lox SCN explants (n = 5) compared to control littermates (n = 8).
(D–F) Circadian variation in expression levels of SCN clock genes Per2 (D), Per2 (E), Bmal1 (C), and Avp (F). ISH labeling intensity was present in adult Lhx1lox/lox
control (D–F) and Six3-Cre;Lhx1lox/lox mutant (D0–F0) mice, with genotype and interaction effects for some genes (n = 3, ANOVA).sometimes of dramatically different periods (Figure 4F). In
contrast, 13% of Vip/ mice on a similar mixed background
became arrhythmic within 3 days of entry into DD; this increased
only to 26% of Vip/ mice over the course of several weeks in
DD (Colwell et al., 2003). A subsequent study of Vip/ mice
backcrossed to C57BL/6 found that 64% of these animals had
badly disrupted rhythms, but most were multirhythmic, not
arrhythmic (Aton et al., 2005).
When a behavioral rhythm is measurable, Six3-Cre;Lhx1lox/lox
free-running rhythms often lacked a clearly dominant rhythm and
were not of significantly different average period than controls,
although individual variability in period length was markedly
greater (Figure 4E). This is in contrast to Vip/ mice, which
regardless of genetic background consistently have a clear
dominant rhythm with a significantly shorter period than wild-
type mice (Aton et al., 2005; Colwell et al., 2003).Advanced phase angle and increased activity during the LD
light phase also suggested Six3-Cre;Lhx1lox/lox mice have de-
fects in light-dependent activity suppression. Although such a
decrease was supported by the observation that overall activity
in constant light (LL) andDDwas similar, we noticed a substantial
decrease in activity in mutants under DD relative to controls (Fig-
ure 4G), precluding a conclusion about masking from these data
alone. To more rigorously measure masking, we first examined
acute activity suppression of wheel-running activity by a 3 hr light
pulse from zeitgeber time (ZT) 14–17 and found no significant dif-
ference in masking in Lhx1lox/lox and Six3-Cre;Lhx1lox/lox mice
(Figure S4G).We then examinedmasking under an ultradian light
cycle (3.5 hr light: 3.5 hr dark). Mice do not entrain to this cycle;
instead, light pulses suppress wheel-running activity, permitting
separation of light-masking effects from photoentrainment. The
percentage of activity during the dark portion of the ultradianCell Reports 7, 609–622, May 8, 2014 ª2014 The Authors 613
(legend on next page)
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cycle in Lhx1lox/lox and Six3-Cre;Lhx1lox/lox mice was similar
(Figure S4H). Interestingly, masking does not require the SCN
(Redlin and Mrosovsky, 1999), indicating that specifically SCN-
mediated circadian behaviors are impaired in this mouse line.
This again contrasts with Vip/ mice, which show substantially
elevated activity in response to a dark pulse (Colwell et al., 2003).
Taken together, these data show thatSix3-Cre;Lhx1lox/lox mice
have disrupted circadian behavior including abnormal photoen-
trainment and disrupted free running rhythms, with the latter
seeming substantially more severe than in Vip/ mice. How-
ever, light-dependent masking of locomotor activity is normal
in our mice.
Intact IpRGC Innervation of SCN After Lhx1 Deletion
The abnormal photoentrainment but intact masking of Six3-
Cre;Lhx1lox/lox mice then led us to investigate whether Lhx1
loss altered retinal innervation of SCN. We utilized the
Opn4tau-LacZ mouse to selectively label ipRGCs by X-gal staining
(Gu¨ler et al., 2008; Hattar et al., 2002). Six3-Cre;Lhx1lox/lox;
Opn4taulacZ/+ mutants and Lhx1lox/lox;Opn4taulacZ/+ controls had
similar gross innervation of SCN, olivary pretectal nucleus, and
lateral geniculate nucleus (Figures S4A and S4B). This was
corroborated by labeling all RGCs using intravitreal cholera toxin
tract tracing in Six3-Cre;Lhx1lox/lox mice and controls (Figures
S4C and S4D). We thenmeasured pupillary light reflex and visual
acuity (optokinetic response) to assess the function of ipRGCs
and RGCs, respectively. We found that ipRGCs are functional
in Six3-Cre;Lhx1lox/lox mice, because pupillary light reflex was
comparable to controls under both dim and bright light (Fig-
ure S4E). Six3-Cre;Lhx1lox/lox mice also show an optokinetic
response, but we observed a small but significant reduction in
visual acuity (Figure S4F). This is likely due to defects in
horizontal cell lamination known to occur after Lhx1 deletion
in the developing retina (Poche´ et al., 2007), which is targeted
by our Cre driver (Furuta et al., 2000). Lhx1 does not play a spe-
cific role in the development of any other retinal cell type. Taken
together, these results suggest that deficits in locomotor activity
of Six3-Cre;Lhx1lox/lox mice were not a result of abnormal retinal
input to the SCN.
Behavioral Rhythms of Six3-Cre;Lhx1lox/lox Mice Are
Hypersensitive to Pulses of the SCN Synchronizing
Neuropeptide Grp and Output Neuropeptide Prok2
Given the low-amplitude but persistent molecular and cellular
rhythms in Lhx1-deficient SCN, we hypothesized that an in vivo
pulse of Grp, known to synchronize disorganized SCN cellularFigure 4. Loss of Lhx1 in the SCN Influences Photoentrainment and Le
(A and A0) Representative actograms of wheel-running activity of Lhx1lox/lox (A) and
6 hr advance in the light/dark cycle. Gray shading represents lights off.
(B) Six3-Cre; Lhx1lox/lox mice show a decreased percentage of activity confined
(C) Six3-Cre; Lhx1lox/lox mice show an advanced phase angle in 12:12 LD (n = 10
(D and D0) Representative actograms of wheel-running activity of Lhx1lox/lox (D
Lhx1lox/lox mice showed either arrhythmicitiy or split rhythms under DD.
(E) Quantification of free-running circadian period lengths in DD. Period lengths f
period lengths measured within a single animal are indicated by the same symb
(F) Distribution of circadian phenotypes observed in Six3-Cre;Lhx1lox/lox mice.
(G) Lhx1lox/lox activity is decreased in constant light as compared to constant dar
per group; two-way ANOVA plight = 0.02, pgenotype = 0.02, Bonferroni posttest Lhoscillators in culture (Brown et al., 2005; Maywood et al.,
2011), should consolidate our mutants’ behavioral rhythms. To
allow approximate calculation of circadian time (CT) for the injec-
tions, we selected Six3-Cre;Lhx1lox/lox mice exhibiting the mild-
est subset of splitting phenotypes, including one exceptional
mouse that usually exhibited essentially wild-type behavior, for
our cannulation studies (Figures 5A, 5B, and S5A–S5C). When
ISH was subsequently performed on the SCNs of the cannulated
cohort, higher numbers of cells appeared to be both Lhx1
positive and neuropeptide positive than in previously examined
Six3-Cre;Lhx1lox/lox mice (Figure S5D). This suggested that lower
Cre efficiency was responsible for the better-preserved rhythms
of these animals.
We first determined that an intracerebroventricular (i.c.v.)
saline injection produced no effect regardless of genotype (Fig-
ure 5A). Control mice exhibited phase shifts after Grp cannula-
tion (0.55 hr ± 0.26, p < 0.05, one-tailed paired Student’s
t test), consistent with previous work (Piggins et al., 1995) (Fig-
ures 5B and S5A). Acute inhibition of locomotion was also often
observed (Figure S5A). Surprisingly, visual inspection of acto-
grams from Six3-Cre;Lhx1lox/lox mice after i.c.v. Grp injection
showed considerable deconsolidation of activity rhythms (Fig-
ures 5B0 and S5A0). To quantify this, we compared the number
of animals of both genotypes with measurable circadian phase
before, but not following, Grp administration. We found a signif-
icant deleterious effect of Grp on mutant activity rhythms (post-
injection phase measurable after 7/7 control injections versus
1/5 mutant injections, Fisher’s exact test, p = 0.01).
Given the dramatic deconsolidating effect of Grp, we hypoth-
esized that Lhx1-deficient SCN might be sensitive to pulses of
SCN output neuropeptides that do not normally produce phase
changes in wild-type animals. We tested this by i.c.v. injection of
the SCN output neuropeptide Prok2. We found that i.c.v. Prok2
cannulation acutely inhibited locomotion without affecting either
phase or period in control mice, as previously observed in rat
(Figures 5C and S5B; Cheng et al., 2002). Remarkably, Prok2
significantly altered not just phase but also period in Six3-
Cre;Lhx1lox/lox mice (p < 0.05; Figures 5C–5E and S5B0). Period
shift after a single injection often lasted for many cycles (Fig-
ure S5B0). When rhythms were robust enough to calculate a
more accurate post hoc circadian time of the injection (5/8 injec-
tions), there was clear circadian gating of both period shift (r2 =
0.82) and phase shift (r2 = 0.56), with the largest shifts occurring
closest to the target injection time of CT14 (Figures 5D and 5E).
A prediction from these studies is that Prok2 will produce
larger shifts in phase and period in mutant mice with the greatestads to Loss of Free-Running Circadian Rhythms
Six3-Cre; Lhx1lox/lox (A0) housed in a 12 hr:12 hr light:dark cycle and subject to a
to the dark portion of the light/dark cycle (n = 10,13; p = 0.0002).
, 11; p = 0.02). Data represent mean ± SEM. ***p < 0.001, *p < 0.05.
) and Six3-Cre; Lhx1lox/lox (D0) mice housed in constant darkness. Six3-Cre;
or Six3-Cre; Lhx1lox/lox are those found in mice with split rhythms. The multiple
ol in the mutant graph.
kness. This difference was not observed in Six3-Cre; Lhx1lox/lox mice (n = 9–11
x1 lox/lox DD versus LL, p < 0.05). Data represent mean ± SEM. *p < 0.05.
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Figure 5. The Lhx1-Deficient Circadian System Is Hypersensitive to Cannulation of the SCN Output Molecule Prok2
(A–C) Representative actograms of wheel-running activity of Lhx1lox/lox (A–C) and Six3-Cre;Lhx1lox/lox (A0–C0) mice before and after an i.c.v. injection (red asterisk)
of saline (A), Grp (B), or Prok2 (C) in DD.
(legend continued on next page)
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reduction of SCN neuropeptides. The number of neuropeptider-
gic cells in Six3-Cre;Lhx1lox/lox SCN correlated well with the
magnitude of phase shifts of mutant mice after Prok2 injection
(r2 = 0.92 [Vip], r2 = 0.88 [Grp], r2 = 0.86 [Avp]) and, to some
extent, also with their period shifts (r2 = 0.76 [Vip], r2 = 0.43
[Grp], r2 = 0.38 [Avp]). While fewer Vip and Grp cells correlated
with larger phase and period shifts, Avp cell number had the
opposite relationship (Figures S5D and S5E). In sum, our cannu-
lation studies highlighted the importance of the SCN neuropep-
tide network for buffering and transforming the circadian effects
of its own signaling molecules.
DISCUSSION
Lhx1 Controls Terminal Differentiation of SCN Neurons
In this study, we found that Lhx1 deletion dramatically downre-
gulates expression of several SCN-enriched neuropeptides
crucial for circadian function (Figure 1; Table S1). However, the
expression of pan-neuronal, GABAergic interneuron and other
genes broadly expressed in anterior hypothalamus is largely
intact in Six3-Cre;Lhx1lox/lox SCN, as are SCN-specific genes
first detectable prior to embryonic day 16.5 (E16.5) (Figures
2A–2D and S2A–S2L). This suggests that transcriptional
networks regulating regional identity, neuropeptidergic and
GABAergic cell fate are separate developmental programs in
the SCN. This contrasts with the only other neural system where
Lhx1 is known to dictate neuropeptidergic fate; in spinal cord
inhibitory interneurons, Lhx1 both drives Npy and Enk expres-
sion in conjunction with Lhx5 (Bro¨hl et al., 2008) and helps main-
tain GABAergic fate (Pillai et al., 2007). Lhx5 is not expressed in
developing mammalian SCN, which may lead to Lhx1-depen-
dent, SCN-specific expression of neuropeptides different from
those in spinal interneurons (Bro¨hl et al., 2008).
While Lhx1 deletion also causes a comparatively moderate
loss of neurons by P4 (Figures 2E and S2M), the region’s
gross anatomy remains essentially intact, with most surviving
domain-specific markers retaining normal compartmentalization
(Figures 2A–2D and S2A–S2L). Because SCN neurogenesis is
mostly complete by E16 and TUNEL revealed elevated cell death
in Lhx1-deficient SCN between P0 and P3 (Figures 2F and S2N),
increased neuronal apoptosis likely decreased neuron number.
Apoptosis also increased between P0 and P3 in both control
and mutant SCN. This is in line with the timing of peak cell death
in hamster SCN, which immediately precedes innervation by
the retinohypothalamic tract (Mu¨ller and Torrealba, 1998).
Neuron loss does not cause SCN neuropeptide downregulation,
because many neuropeptidergic populations lost in adult
Lhx1-deficient SCN (Vip, Avp, Grp, and possibly Prok2) are
already reduced in Lhx1-deficient SCN at P0, prior to neuron
loss (Figures 2G and S2O–S2R). Taken together, these data(D and E) Mutants had higher-magnitude phase shifts (D) and period shifts (E) in r
*p < 0.05; bar graphs depict mean ± SEM). Both phase and period shifts in mutan
CT versus phase or period shift of individual injections).
(F) A model of SCN neuropeptide dynamics. Synchronizing factors are shown i
implications for synchrony are shown in black. The following insights gained from
signals like Grp can be contingent on interpretation by the broader network, and (ii
of feedback signaling from SCN outputs like Prok2 that would otherwise alter it.indicate that increased apoptosis and neuron loss are likely
secondary to defects in SCN terminal differentiation in Six3-
Cre;Lhx1lox/lox SCN.
Given that Lhx1 is first detectable at E11.5 when SCN
neurogenesis begins, we initially hypothesized that Six3-Cre;
Lhx1lox/lox mice would have an early SCN specification defect,
akin to neuronal progenitor-specific deletion of Six3 (VanDunk
et al., 2011) or constitutive deletion of Six6 or Lhx2 (Clark et al.,
2013; Roy et al., 2013), rather than a terminal differentiation
defect. Preservation of early-onset markers in Lhx1mutants sug-
gests that any role of Lhx1 in early SCN differentiation is redun-
dant with other factors up to E16.5. One candidate is Lhx8, a
close Lhx1 homolog coexpressed with Lhx1 in developing SCN
from E11.5 until E16.5, when Lhx8 is downregulated (Shimogori
et al., 2010). Future analysis of Lhx1/Lhx8 doublemutants should
resolve whether the latter is partially compensating for Lhx1
deletion.
More broadly, Lhx1’s central role in terminal differentiation of
multiple neuropeptidergic cell types in SCN presents an oppor-
tunity to dissect the transcriptional network guiding SCN cell
fate determination. Leveraging this starting point, future investi-
gations will be able to isolate both upstream regulators of Lhx1
expression and downstream factors that further subdivide SCN
neuropeptidergic populations. Combined with identification of
factors involved in initial SCN specification, such as Six3, Six6,
and Lhx2 (Clark et al., 2013; Roy et al., 2013; VanDunk et al.,
2011), this line of study could eventually allow stem cell lineages
to be differentiated into specific SCN cell types, with profound
implications for treatment of circadian-related sleep distur-
bances, mood disorders, and other pathologies.
Lhx1 Is Required for Normal SCNCellular andBehavioral
Rhythmicity
Despite loss of expression of multiple neuropeptides involved in
synchronization of SCN oscillators in Six3-Cre;Lhx1lox/lox mice,
rhythms of Per2::luciferase expression in SCN slice cultures
showed normal average period and only moderately damped
amplitude (Figure 3A). CCD imaging showed this was due to
reduced cellular synchrony and increased period variability in
Lhx1-deficient SCN (Figure 3B-C). Furthermore, our ISH time
course showed that clock and clock-controlled gene expression
is still temporally regulated in vivo after Lhx1 deletion (Figures
3D–3F and S3A–S3C). These deficits are similar to what has
been observed shortly after culturing Vipr2/SCN slices (Brown
et al., 2007).
The severe circadian deficits in Six3-Cre;Lhx1lox/lox DD activity
rhythms were unexpected given the moderate effects on SCN
oscillators in these animals (Figures 3 and 4). Although some
mutants had milder splitting phenotypes (Figures 4F, 5, S5A,
and S5B), most had multiple rhythms with distinct periods oresponse to Prok2 than controls (left) (n = 8, two-tailed heteroscedastic t tests,
ts were gated by injection CT (right) (n = 5, linear regression, scatterplots depict
n green, desynchronizing factors are shown in red, and factors without clear
our study are highlighted: (i) synchronizing and desynchronizing effects of SCN
) core neuropeptidesmay buffer circadian period length, stabilizing it in the face
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had no measurable rhythms at all (Figures 4D and 4F). Typically,
behavioral rhythms are more, not less, well organized than
those of cellular clocks (Aton et al., 2005; Colwell et al., 2003;
Harmar et al., 2002), making our observations unusual. Severe
behavioral disorganization, normal average circadian period, a
lack of altered activity rhythm masking by darkness, and the
disconnect between robustness of cellular and behavioral
rhythms all suggest that the phenotype of Lhx1 deletion in SCN
is not simply a product of Vip loss (Aton et al., 2005; Colwell
et al., 2003).
The most likely explanation rationalizing our SCN clock and
behavioral data is that loss of expression of SCN neuropeptides
following Lhx1 deletion leads the SCN to become not only
internally disorganized but also uncoupled from downstream
oscillators in the absence of external light cues. This suggests
that Lhx1-regulated neuropeptide(s) and/or other signals could
constitute the unidentified paracrine signals proposed to be suf-
ficient for synchronization of peripheral oscillators by SCN (Silver
et al., 1996). Prok2 is one likely component, because Prok2/
SCN also seems to have a reduced ability to drive circadian
rhythms (Li et al., 2006); however, the low percentages of
Prok2/ mice with severely disrupted rhythms (13% in mixed
background and 20% after backcrossing to C57BL/6) suggest
that it alone cannot account for the entirety of the Six3-Cre;
Lhx1lox/lox phenotype. On the other hand, phase-advanced pho-
toentrainment in Six3-Cre;Lhx1lox/lox mice, with an activity onset
before dark, suggests that the Lhx1-deficient SCN does engage
downstream oscillators when driven by light. Light entrainment
may coordinate remaining SCN outputs, such as GABA (Moore
and Speh, 1993), to preserve activity rhythms under light-dark
conditions.
Finally, Lhx1-deficient mice did not decrease their activity in
response to constant light, reflecting a decrease in overall activ-
ity (Figure 4G), despite having intact masking (Figures S4G and
S4H). IpRGCs do not appear to contribute to this defect; they
are functional and innervate their targets normally (Figures
S4A–S4D). Both Vip/ andProk2/mice have decreased over-
all activity levels under DD (Colwell et al., 2003; Li et al., 2006);
loss of these and other neuropeptides following Lhx1 deletion
may act synergistically to drop DD activity to the same low, com-
mon baseline seen in wild-type mice in LL.
Implications for SCN Clock Function
Induction of arrhythmicity in Six3-Cre;Lhx1lox/lox mice given i.c.v.
Grp (Figure 5B) suggests that whether a given neuropeptide pro-
motes synchronization or desynchronization is not an intrinsic
property of the molecule and its receptors alone. Instead, the
effects of a given neuropeptide on synchrony also seem to
depend on interpretation by the broader SCN neuropeptide
network. It is known that large doses of Vip can transiently
disrupt rhythms in normal mice, both in slice culture and in vivo,
but that even very high doses of Grp fail to mimic this effect (An
et al., 2013), and it has long been known that normal micemerely
phase shift in response to exogenous Grp (Piggins et al., 1995).
Based on the literature, one would expect excess Grp to help
consolidate activity in Lhx1-deficient mice, as it does in slice cul-
tures of Vip/ SCN (Brown et al., 2005; Maywood et al., 2011).
Instead, quite the opposite occurs, suggesting that another618 Cell Reports 7, 609–622, May 8, 2014 ª2014 The Authorssignaling molecule(s) present in the Vip/ SCN underpins
Grp’s synchrony-promoting activity.
Similarly, after i.c.v. Prok2 injection in Six3-Cre;Lhx1lox/lox
mice, dramatic changes in not just phase-shift magnitude, as
might be predicted when the SCN oscillator is damped (Vitaterna
et al., 2006), but also period length (Figures 5C–5E and S5C–
S5E) were surprising. This neuropeptide has no effect on phase
or period in wild-type animals (Cheng et al., 2002), which we
reproduce in our study. The dramatic differences in the effects
of Prok2 infusion in wild-type and Lhx1-deficient mice indicate
a previously unappreciated Lhx1-dependent role for the SCN
in buffering changes in phase and period induced by infusion
of SCN-derived output neuropeptides. This provides insight
into a central problem faced by the SCN: how to prevent
changes in the central oscillator induced by both its own activity
and afferent inputs from other brain regions, some of which use
the same neurotransmitters, including Prok2 (Cheng et al., 2006;
Krout et al., 2002).
We propose that period buffering is at least partially mediated
by the core neuropeptides Vip and Grp. Their mRNA expression
negatively correlated with the magnitude of both phase and
period changes after i.c.v. Prok2 infusion (Figures S5D and
S5E), consistent with extending the peptides’ well-documented
ability to increase central oscillator robustness and thus control
of circadian phase (Kuhlman et al., 2003; McArthur et al., 2000;
Piggins et al., 1995) to stabilization of circadian period in the
face of perturbation by SCN output molecules. Meanwhile,
expression of Avp positively correlated with both phase-shift
magnitude and change in period length (Figure S5D and S5E),
consistent with its role in relaying circadian clock signals to
the SCN core (Leak and Moore 2001; Schwartz et al., 2010).
To what extent the in vivo circadian system is susceptible to
Prok2 infusion when only core neuropeptides are lost, as in
the Vip/ mouse, presents an interesting question for future
study.
In sum, our functional findings may explain why the SCN
selectively expresses so many different neuropeptides, with sig-
nals from each individual neuropeptide cooperating to synergis-
tically enhance behavioral stabilization (Figure 5F). Because the
SCN expresses at least half a dozen different neuropeptides that
are absent or greatly reduced in Six3-Cre;Lhx1lox/lox mice, this is
a finding that is only readily obtainable using a developmental
genetic approach that globally disrupts SCN neuropeptide
expression and that would have beenmissed using conventional
behavioral, pharmacological, or individual neuropeptide-muta-
tion approaches.
Summary
Our work identifies distinct transcriptional networks selectively
regulating SCN terminal differentiation, as opposed to initial
SCN specification. Specifically, our study shows that Lhx1 loss
selectively disrupts SCN terminal differentiation, leading to a fail-
ure to induce many neuropeptides crucial for normal circadian
function (Figures 1 and 2). This discovery provides an entry point
to dissect the transcriptional networks underlying development
of the master clock and eventually determine how the region
acquires its many unique circadian properties during early post-
natal life.
Despite profound disruption of many components of the neu-
ropeptide network, Six3-Cre;Lhx1lox/lox SCN rhythms are no
more disrupted than those seen in Vip/ SCN; however, Six3-
Cre;Lhx1lox/lox mice show much more defective free-running
circadian activity rhythms than anticipated from the disruption
of their cellular clocks, particularly in the absence of light input
(Figures 3 and 4). We believe that these phenotypes suggest a
profound SCN output deficit in these animals; therefore, they
will be useful for determining the contribution of multiple SCN
neuropeptides in controlling coupling between the SCN and
peripheral oscillators and the role of this coupling in regulating
physiology and cognition.
Finally, our data extend the field’s understanding of the highly
interdependent nature of individual SCN neuropeptides’ func-
tions (Figure 5F). The desynchronizing effects of exogenous
Grp in our Six3-Cre;Lhx1lox/lox mice suggest that interactions
among SCN neuropeptide signals can completely transform
the effect of some signals on behavioral synchrony. Furthermore,
our Prok2 cannulation studies identify a role for Lhx1-dependent
elements of the SCN network, likely including the core neuropep-
tides Vip and Grp, in maintaining robust circadian period length,
as well as phase, in response to changing levels of secreted SCN
output neuropeptides such as Prok2.
EXPERIMENTAL PROCEDURES
Animals and Housing
Six3-Cre;Lhx1lox/lox and control Lhx1lox/lox mice were used, with the following
exceptions: Six3-Cre;Lhx1lox/lox;Opn4lacZ/+ and Lhx1lox/lox;Opn4lacZ/+ mice for
X-gal staining, Six3-Cre;Lhx1lox/lox; Per2luc/+ and Lhx1lox/lox;Per2luc/+ mice for
luciferase imaging, and Six3-Cre;ROSA26::YFP mice for Cre mapping. Genet-
ically modified mice were provided by Y. Furuta (Six3-Cre), R. Behringer
(Lhx1lox/lox), and Jackson Laboratories (Per2::luc). Behavioral studies used
males; other experiments used both sexes. Except where otherwise noted,
mice were on a 15 hr:9 hr light:dark cycle. All mice were mixed C57BL6/
Sv129 background. All controls were littermates. All procedures and care
were approved by Johns Hopkins Institutional Animal Care and Use Commit-
tee, in line with National Institutes of Health guidelines for experimental
animals.
Genotyping
Transnetyx conducted most genotyping using proprietary methods. Some
floxed Lhx1 alleles were genotyped as described previously (Kwan and Beh-
ringer, 2002), and some Cre was detected by presence of a 300 bp band
amplified using primers 50-TTCCCGCAGAACCTGAAGAT-30 and 50-CCCCA
GAAATGCCAGATTAC-30.
Tissue Collection and Preparation
Brains were dissected, fresh frozen in OCT (Tissue-Tek) at the desired age,
and stored at 80C. Each experimental/control pair was collected in the
same session. Clock gene time course mice were entrained to LD, moved to
DD for 24 hr, and sacrificed in 4 hr increments on DD day 2. Next, 25 mm serial
sections were cut on a Leica CM3050-S cryostat, thawmounted on Superfrost
Plus slides (Fisher), and stored at 80C. Five adjacent slide sets were pre-
pared for ISH; two were prepared for IHC and TUNEL.
In Situ Hybridization
Probes were selected and tissue processed as previously described (Shimo-
gori et al., 2010).
Immunohistochemistry
Slides were fixed in 4% paraformaldehyde in 13 PBS, blocked in Superblock
(Thermo Scientific), and then incubated overnight at 4C in 1:200 monoclonalmouse immunoglobulin G (IgG) 2b anti-human-HuC/D (Invitrogen) or 1:500
polyclonal rabbit IgG anti-GFP (Molecular Probes) in PBS (5% horse serum,
0.16% Triton X-100 in 1X PBS). Slides were then incubated in 1:500 goat
anti-mouse Alexa 568 IgG (Molecular Probes) or 1:500 donkey anti-rabbit
Alexa 488 IgG (Molecular Probes), DAPI stained, and coverslipped with
Gelvatol.
TUNEL Assay
Slides were processed with TMR Red In Situ Cell Death Kit (Roche) following
the manufacturer’s instructions for cryopreserved tissue.
X-Gal Stain
Slides were processed as described previously (Hattar et al., 2002).
Cholera Toxin Labeling
Mice were anesthetized with Avertin (20 mg/ml). Eyes were injected intravi-
treally with 2 ml cholera toxin B subunit (CTb) conjugated to Alexa Fluor 488
(Invitrogen). Three days later, mice were deeply anesthetized with 1 ml Avertin
and transcardially perfused with 4% formalin. Brains were removed, postfixed
2 hr in 4% formalin, cryoprotected in 30% sucrose, and frozen in OCT (Tissue-
Tek). Next, 50 mm sections were cut and free-floated in 0.1 M phosphate
buffer, blocked (0.1 M phosphate buffer, 3% Triton X-100, 0.5% BSA, 1.5%
rabbit serum) for 1 hr, incubated in goat anti-CTb (List Biologicals, 1:8,000)
overnight at 4C, and visualized with rabbit anti-goat Vectastain horseradish
peroxidase kit (Vector Labs) using 3,3-diaminobenzidine (Sigma). Sections
were mounted, dehydrated, and coverslipped with Permount and then viewed
on a Zeiss Axio Imager M1 microscope.
Cell Counting
Slides were imaged by epifluorescence or bright field (Axioskop 2 Mot Plus,
Zeiss Microscopy). After blinded manual counting of labeled SCN cells, total
cells per hemisphere were estimated. Three brains per genotype per marker
were counted. Statistical analysis was done in Excel (paired two-way t test)
or Prism (two-way ANOVA with Tukey post hoc tests).
Circadian Time Course Densitometry
Slides were imaged by bright field (Axioskop 2 Mot Plus, Zeiss Microscopy)
and analyzed in ImageJ. Rolling ball correction was applied to reduce back-
ground. Signal intensity from 0 to 255 arbitrary units was calculated in both
SCN hemispheres and two cell-poor areas per image. Intensity of cell-poor re-
gions was subtracted from SCN intensity, and mean and SEM d-intensity for
each brain was computed in Excel. Two-way ANOVA analysis was done in
Prism. Three brains per genotype per time point were used.
Real-Time Per2::Luciferase Measurement and Analysis
SCN slices were cultured and maintained at 36C in darkness. Biolumines-
cence from each culture was either integrated every minute with a photomul-
tiplier tube or for 15 s every 10 min with a CCD camera. Photomultiplier tube
data were analyzed using modified published methods (Herzog et al., 2004).
CCD data were stacked as previously described (Schindelin et al., 2012) and
analyzed over 101 2 3 2 pixel regions of interest. See Supplemental Experi-
mental Procedures for details.
Wheel-Running Activity
Mice were housed individually with a 4.5-inch running wheel and ad libitum
food and water. Wheel running was monitored using Vitalview (Mini Mitter).
Photoentrainment was assayed in a 12 hr:12 hr light:dark cycle (LD). Free-
running circadian rhythms were assessed in constant darkness (DD) and con-
stant light (LL). Light intensity in LD and LL was 600 lux, provided by Philips
Daylight deluxe fluorescent lamps. Clocklab (Actimetrics) was used to
generate actograms and measure circadian periods. A 3 hr light pulse from
ZT 14–17 was used to measure acute activity suppression (masking) by light.
Wheel revolutions were quantified during the pulse and normalized to the pre-
vious day where mice were undisturbed in the dark. A 1-week 3.5 hr:3.5 hr
light:dark ultradian light cycle was also used to measure masking. Wheel
revolutions were quantified to determine total activity during light and dark
phases. Data were analyzed by Student’s t test.Cell Reports 7, 609–622, May 8, 2014 ª2014 The Authors 619
Stereotaxic Cannulation and i.c.v. Injections
Surgeries and targeting validation were performed as described previously
(Byerly et al., 2013). Briefly, unilateral cannulas were implanted in lateral
cerebral ventricle of anesthetized mice. Successful cannula placement was
verified in four Six3Cre;Lhx1lox/lox and four Lhx1 lox/lox mice by measuring
feeding after NPY i.c.v. injection. A total of 2 ml of 114 mM Prok2, Grp, or
saline vehicle was i.c.v. injected under dim red light into mice free-running
in DD, at estimated CT 14. See Supplemental Experimental Procedures for
details.
Optomotry
Behavior was assessed as described previously (Chen et al., 2011). Briefly,
animals were adapted for 5 min to an elevated platform centered in a virtual
cylinder. A sine wave grating was presented and acuity was assessed by the
staircase method; stimulus tracking was recorded from above. Each mouse
was tested in triplicate.
Pupillary Light Reflex
Behavior was assessed as described previously (Chen et al., 2011). Briefly,
pupil size of one eye was video recorded for 15 s after 1 hr dark adaptation
and then 30 s while the opposite eye was stimulated with a 470 nm light-emit-
ting diode. Percent constriction relative to dark-adapted baseline was calcu-
lated from images captured from the video. Measurements were restricted
to midday (ZT 4–8). Responses to low (22 mW cm2) and high (5.66 mW cm2)
light intensities were recorded.
Motif Pair Tree Bioinformatic Analysis
The Lhx1 transcription factor binding site position weight matrix was down-
loaded from the Bulyk PDM Database (http://the_brain.bwh.harvard.edu/
pbms/webworks2/explore.php). Proximal enhancer regions (2 kb upstream
and 1kb downstream of transcription start site) were extracted from annotated
reference genes, and only sequences conserved between mouse and human
genomeswere considered.We identified Lhx1 binding sites withmotif pair tree
(MOPAT) software (Hu et al., 2008), with 0.0001 as the p value cutoff defining
positive hits.
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